Table 3

EQ-5D quality of life utilities associated with lifetime and current comorbidities in rheumatoid arthritis (RA).

Lifetime Comorbidity(+)(−)AUC(c)Current Comorbidity(+)(−)AUC(c)
Depression0.670.780.687Psychiatric0.550.740.745
Neurological0.670.740.591Depression0.600.770.747
Psychiatric disorder0.670.780.681Psychiatric disorder0.600.770.732
Psychiatric0.680.740.582Fracture0.610.740.676
Diabetes0.680.750.590Neurological0.610.740.691
Pulmonary0.680.750.601Gall bladder0.620.740.656
Fracture0.680.750.602Allergy0.640.750.648
Myocardial infarction0.690.740.560Asthma0.640.750.640
CVO0.690.750.590Stroke0.640.740.663
Stroke0.690.740.562Liver0.640.740.650
ETOH0.690.740.559Myocardial infarction0.640.740.612
Renal0.690.740.582Pulmonary0.640.740.650
Asthma0.690.750.592Ulcer0.640.740.648
Allergy0.690.750.600Renal0.640.740.645
Liver0.690.740.576GI0.650.750.647
Ulcer0.690.750.661Pulmonary disorder0.650.750.642
GI0.690.760.605CVO0.660.740.629
Heart disorder0.690.750.589GU0.660.740.597
Pulmonary disorder0.690.760.597GI disorder0.660.750.649
Gall bladder0.700.750.571Heart disorder0.660.740.627
GI disorder0.700.770.613Diabetes0.670.740.612
Hypertension0.710.760.577ETOH0.680.740.606
Cataract0.710.750.532Cataract0.690.740.566
GU0.710.750.568Hypertension0.700.760.588
Endocrine disorder0.710.750.553Endocrine disorder0.700.750.572
Thyroid-endocrine0.730.740.524Cancer0.710.740.524
Cancer0.740.740.497Thyroid endocrine0.720.740.542
  • 7008 patients with RA, adjusted for age and sex. (+): EQ-5D score for those with comorbid condition. (−): EQ-5D score for those without the comorbid condition. AUC(c): area under receiver operating curve (Harrell’s c); CV: cardiovascular; CVO: other cardiovascular; GI: gastrointestinal; GU: genitourinary disorder; ETOH: ethanol.